HB

H. Bosch

Botanix Pharmaceuticals Ltd | Executive Director
Dr Bosch is an accomplished pharmaceutical executive with more than 30 years of experience and industry leadership in pharmaceutical R&D. Dr. Bosch served as CSO of iCeutica where he was the principal architect of SoluMatrix drug delivery technology, used in four FDA approved prescription drug products. Earlier in his career Dr. Bosch was a pioneer in the application of nanotechnology to pharmaceutical product development. He served as a co founder of NanoSystems LLC in 1995 and co-inventor of NanoCrystal Technology, leading to the successful development and FDA approval of seven prescription drug products for a variety of indications and routes of administration.

Company and Role

Company
Title
Tenure
Since
BOT
Botanix Pharmaceuticals Ltd
  • Executive Director
8yrs, 2mthJul 2016

Holding

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
BOT
Botanix Pharmaceuticals Ltd
29/09/2318,836,702N/AN/AN/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
BOT
Botanix Pharmaceuticals Ltd
18/05/23
Buy
500,000$0.085$42,500Conversion of securities
BOT
Botanix Pharmaceuticals Ltd
18/05/23
Exercise
500,000$0.085$42,500Conversion of securities
BOT
Botanix Pharmaceuticals Ltd
20/03/23
Exercise
500,000$0.097$48,500Conversion of securities
BOT
Botanix Pharmaceuticals Ltd
20/03/23
Buy
500,000$0.097$48,500Conversion of securities
BOT
Botanix Pharmaceuticals Ltd
03/01/23
Issued
1,500,000$0.052$78,000Issue of securities